Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-02

Clinical Trial Update: Jaktinib Hydrochloride Cream For Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for jaktinib hydrochloride cream in atopic dermatitis across Phase 1 and Phase 2, with study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jaktinib hydrochloride cream (jaktinib hydrochloride)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED